Evonile Pharma Rights Issue Review: Should Investors Subscribe?

Evonile Pharma’s ₹860 rights issue, covering the 5:12 entitlement, recent losses, share price performance and debt reduction. Evonile Pharma Ltd is coming out with its Rights Issue (RI) of 10287832 equity shares... Read more »